Get the Stockscreener App
43.96
4.34%
1.83
Bright Minds Biosciences Inc stock is traded at $43.96, with a volume of 29,142.
It is up +4.34% in the last 24 hours and up +66.42% over the past month.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
See More
Previous Close:
$42.13
Open:
$42.21
24h Volume:
29,142
Relative Volume:
0.64
Market Cap:
$309.65M
Revenue:
-
Net Income/Loss:
$-4.98M
P/E Ratio:
-33.36
EPS:
-1.3177
Net Cash Flow:
$-3.85M
1W Performance:
+5.12%
1M Performance:
+66.42%
6M Performance:
+22.15%
1Y Performance:
+4,168%
1-Day Range:
$42.21
$44.24
1-Week Range:
$41.00
$46.13
52-Week Range:
$0.94
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Name
Bright Minds Biosciences Inc
Sector
Industry
Phone
-
Address
-
Compare DRUG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
43.96 | 322.64M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-13-25 | Initiated | TD Cowen | Buy |
| May-07-25 | Initiated | Chardan Capital Markets | Buy |
| Jan-23-25 | Initiated | Piper Sandler | Overweight |
| Jan-10-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-25 | Initiated | H.C. Wainwright | Buy |
| Nov-26-24 | Initiated | Robert W. Baird | Outperform |
View All
Bright Minds Biosciences Inc Stock (DRUG) Latest News
Bright Minds Biosciences Reports Q3 2025 Financial Results - MSN
Bright Minds Biosciences stock maintains Buy rating at H.C. Wainwright - Investing.com
Applying Wyckoff theory to Bright Minds Biosciences Inc. stockPortfolio Risk Summary & AI Powered Market Trend Analysis - Newser
Bright Minds Biosciences (NASDAQ:DRUG) Given Buy Rating at HC Wainwright - Defense World
Visual analytics tools that track Bright Minds Biosciences Inc. performanceQuarterly Market Review & Real-Time Sentiment Analysis - Newser
Analyzing Bright Minds Biosciences Inc. with risk reward ratio charts2025 Volatility Report & AI Powered Buy/Sell Recommendations - Newser
New Product Launches: Will They Boost Bright Minds Biosciences Inc. Stock in 2025Market Rally & Advanced Technical Signal Analysis - Newser
Using economic indicators to assess Bright Minds Biosciences Inc. potentialJuly 2025 Pullbacks & Capital Protection Trading Alerts - Newser
How to read the order book for Bright Minds Biosciences Inc.Quarterly Market Summary & Reliable Price Action Trade Plans - Newser
What makes Bright Minds Biosciences Inc. stock price move sharplyStop Loss & Stepwise Swing Trade Plans - Newser
Using flow based indicators on Contineum Therapeutics Inc.Weekly Stock Recap & Weekly Stock Performance Updates - Newser
Bright Minds Biosciences Inc. stock outlook for YEAR2025 Bull vs Bear & AI Forecasted Stock Moves - Newser
Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Price Target at $83.25 - Defense World
How to track smart money flows in Bright Minds Biosciences Inc.2025 Technical Patterns & Smart Investment Allocation Tips - Newser
Smart tools for monitoring Bright Minds Biosciences Inc.’s price action2025 Analyst Calls & Free Community Supported Trade Ideas - Newser
Bright Minds Biosciences Inc. Stock Recovery Path — Analyst BreakdownMarket Rally & Reliable Price Breakout Alerts - beatles.ru
Bright Minds rally ends as psychedelic stocks extend volatility - MSN
Quantitative breakdown of Bright Minds Biosciences Inc. recent moveIndex Update & AI Enhanced Trading Alerts - Newser
Earnings visualization tools for Bright Minds Biosciences Inc.Trade Volume Report & AI Powered Buy/Sell Recommendations - Newser
Analyzing Bright Minds Biosciences Inc. with risk reward ratio charts [Portfolio Risk Report]High Yield Stock Recommendations - Newser
Chart based exit strategy for Bright Minds Biosciences Inc.Free Weekly Setup With 3x Return Potential - Newser
Bright Minds Biosciences (DRUG) Projected to Post Earnings on Wednesday - Defense World
How Bright Minds Biosciences Inc. stock performs during market volatilityWeekly Chart Watchlist with Trade Guidance - Newser
Full technical analysis of Bright Minds Biosciences Inc. stockSwing Entry Risk Mitigation with Chart Analysis - Newser
Can Bright Minds Biosciences Inc. stock recover from recent declinePredictable Income Summary for Long-Term Trades - Newser
How to build a dashboard for Bright Minds Biosciences Inc. stockRisk-Managed Swing Setup and Signal Analysis - Newser
Bright Minds Biosciences Inc. Earnings Report Breakdown: What Investors Should KnowReal-Time Investment Signal Forecast with AI - Newser
Bright Minds Biosciences Inc Stock (DRUG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bright Minds Biosciences Inc Stock (DRUG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% Owner |
Oct 15 '24 |
Buy |
5.53 |
372,591 |
2,061,574 |
825,000 |
| Cormorant Asset Management, LP | 10% Owner |
Oct 16 '24 |
Buy |
23.46 |
50,000 |
1,172,813 |
875,000 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):